ARGENTINA

EQS-News: action press strengthens night production with new location in Buenos Aires

Retrieved on: 
Wednesday, April 10, 2024

Frankfurt/Hamburg, April 9, 2024 - action press AG picture agency group is strengthening its night production with the opening of its third international location in Buenos Aires.

Key Points: 
  • Frankfurt/Hamburg, April 9, 2024 - action press AG picture agency group is strengthening its night production with the opening of its third international location in Buenos Aires.
  • Two editors mainly manage the production of entertainment content in video format during the nighttime hours in Europe.
  • The editorial office in Buenos Aires is being opened in collaboration with the Grosby Group (Los Angeles) American agency, which is providing action press with both the office and specialized editorial staff.
  • A total of 18 photo editors and photographers are working on behalf of action press in New Zealand and Australia.

Holcim to acquire Tensolite

Retrieved on: 
Wednesday, April 10, 2024

Holcim has signed an agreement to acquire Tensolite, a leading manufacturer of innovative precast and pre-stressed concrete construction systems with $22 million of net sales in 2023 and a strong presence in fast-growing Latin American markets.

Key Points: 
  • Holcim has signed an agreement to acquire Tensolite, a leading manufacturer of innovative precast and pre-stressed concrete construction systems with $22 million of net sales in 2023 and a strong presence in fast-growing Latin American markets.
  • With plants and a distribution network across Argentina, Paraguay and Uruguay, Tensolite will expand Holcim’s Solutions & Products portfolio and strengthen its geographical footprint.
  • Oliver Osswald, Region Head Latin America, said: “By acquiring Tensolite, we are further expanding our Solutions & Products portfolio in Latin America and globally.
  • I am excited to further grow Tensolite and to welcome all 155 employees to the Holcim family.”
    Tensolite was founded in 1979 and specializes in concrete construction systems from joists and roof tiles, to customized products for large civil works, from bridge beams and precast to grandstands and walkways.

SSR Investors: Investors with Significant Losses Should Contact Robbins LLP About the SSR Mining Inc. Class Action

Retrieved on: 
Tuesday, April 9, 2024

SSR Mining purports to be a “precious metals mining company with four producing assets located in the United States, Türkiye [“Turkey”], Canada and Argentina.

Key Points: 
  • SSR Mining purports to be a “precious metals mining company with four producing assets located in the United States, Türkiye [“Turkey”], Canada and Argentina.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • The Allegations: Robbins LLP is Investigating the Allegations that SSR Mining Inc. (SSRM) Misled Investors Regarding its Safety Practices
    According to the complaint, during the class period, defendants failed to disclose that (1) they materially overstated SSR Mining’s commitment to safety and the efficacy of its safety measures, and (2) SSR Mining engaged in unsafe mining practices, which were reasonably likely to result in a mining disaster.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

A.I.S. to Focus Efforts on Gold Exploration in Australia

Retrieved on: 
Tuesday, April 9, 2024

Resources Limited ( TSX-V: AIS, OTC-PINK: AISSF, FRA: 5YHA ) (the “Company” or “AIS”) announces a renewed focus on gold exploration in Australia.

Key Points: 
  • Resources Limited ( TSX-V: AIS, OTC-PINK: AISSF, FRA: 5YHA ) (the “Company” or “AIS”) announces a renewed focus on gold exploration in Australia.
  • AIS will receive 15% of gold sales revenue emanating from the Vendor’s mining activities outside of the Vendor’s prospecting license.
  • Andrew Neale, President & CEO of AIS commented, “The significant increase in gold prices has renewed interest in gold exploration, and the three properties in Australia are ready for immediate on-site work.
  • In early March, AIS completed a 1-for-10 reverse stock split as part of ongoing corporate restructuring efforts, reducing the total share count to approximately 20 million shares

Green Shift Closes Previously Announced Sale of the Berlin Project, Colombia

Retrieved on: 
Tuesday, April 9, 2024

TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Green Shift Commodities Ltd. (TSXV: GCOM and OTCQB: GRCMF), (“Green Shift”, “GCOM” or the “Company”) is pleased to announce that it has closed the previously announced (see previous press release dated December 11, 2023), sale (the “Transaction”) of its Berlin Project (“Berlin” or the “Project”) located in Caldas, Colombia to Jaguar Uranium Corp. (formally Latam Battery Metals Inc.) (“Jaguar”).

Key Points: 
  • TORONTO, April 09, 2024 (GLOBE NEWSWIRE) -- Green Shift Commodities Ltd. (TSXV: GCOM and OTCQB: GRCMF), (“Green Shift”, “GCOM” or the “Company”) is pleased to announce that it has closed the previously announced (see previous press release dated December 11, 2023), sale (the “Transaction”) of its Berlin Project (“Berlin” or the “Project”) located in Caldas, Colombia to Jaguar Uranium Corp. (formally Latam Battery Metals Inc.) (“Jaguar”).
  • Trumbull Fisher, CEO and Director of GCOM, commented, “We are pleased to complete this transaction which offers GCOM several benefits.
  • Firstly, with multiple lithium exploration opportunities, our portfolio now appropriately reflects our exploration focus and technical expertise in Canada and Argentina.
  • GCOM issued 3,333,333 common shares to Generic Capital Corp. as compensation for advisory services in connection with the Transaction.

Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer

Retrieved on: 
Monday, April 8, 2024

“Fully enrolling ROSELLA takes us a big step closer to addressing the unmet medical need of women with platinum-resistant ovarian cancer,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.

Key Points: 
  • “Fully enrolling ROSELLA takes us a big step closer to addressing the unmet medical need of women with platinum-resistant ovarian cancer,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.
  • “Relacorilant has the potential to become the standard of care for patients with this devastating disease.
  • The ROSELLA trial enrolled 381 women at sites in the United States, Europe, South Korea, Brazil, Argentina, Canada and Australia.
  • Patients were randomized 1:1 to receive either relacorilant dosed intermittently with nab-paclitaxel or nab-paclitaxel monotherapy.

Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association

Retrieved on: 
Wednesday, April 3, 2024

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present nine abstracts in rare kidney disease at the World Congress of Nephrology (WCN) in Buenos Aires, Argentina, on April 13-16, 2024, and the American Nephrology Nurses Association (ANNA) National Symposium in Orlando, Florida, on April 14-17, 2024.

Key Points: 
  • SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present nine abstracts in rare kidney disease at the World Congress of Nephrology (WCN) in Buenos Aires, Argentina, on April 13-16, 2024, and the American Nephrology Nurses Association (ANNA) National Symposium in Orlando, Florida, on April 14-17, 2024.
  • At WCN, the Company will present subgroup analyses of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgA nephropathy (IgAN) showing the treatment effect across participants with different levels of baseline proteinuria.
  • At ANNA, the Company will present additional insights from the HONUS trial, including health-related quality of life (HRQoL) data and the humanistic burden experienced by patients with IgAN and focal segmental glomerulosclerosis (FSGS).
  • “The data we are presenting at WCN and ANNA reinforce the wealth of evidence supporting FILSPARI’s profile to become an effective foundational treatment replacing RAAS inhibition, with the potential to reduce the lifetime risk of kidney failure for patients with IgAN,” said Jula Inrig, M.D., chief medical officer of Travere Therapeutics.

SSRM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SSR Mining Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Wednesday, April 3, 2024

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SSR Mining Inc. (“SSR Mining” or “the Company”) (NASDAQ: SSRM) and certain of its officers.

Key Points: 
  • NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SSR Mining Inc. (“SSR Mining” or “the Company”) (NASDAQ: SSRM) and certain of its officers.
  • SSR Mining purports to be a “precious metals mining companywith four producing assets located in the United States, Türkiye [“Turkey”], Canada and Argentina.
  • If you suffered a loss in SSR Mining you have until May 17, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Demand Climbs as Global Lithium Market Size Expected to Reach $9.03 Billion in 2024

Retrieved on: 
Tuesday, April 2, 2024

A report from Grand View Research said that revenues will reach USD 9.03 billion in 2024 and the Increasing investments in EV manufacturing across the world are expected to positively influence the growth of the lithium market over the forecast period (2024 to 2030).

Key Points: 
  • A report from Grand View Research said that revenues will reach USD 9.03 billion in 2024 and the Increasing investments in EV manufacturing across the world are expected to positively influence the growth of the lithium market over the forecast period (2024 to 2030).
  • In 2018, Interior Department listed lithium as a critical mineral, which paced up the mine permitting process.
  • Grand View Research continued: “The market is characterized by a high degree of innovation to optimize both the manufacturing process, and also obtain high purity lithium.
  • Players have invested in R&D heavily to optimize the usage of lithium in high-growth end use segments such as electric vehicles.

Bitfarms Announces March 2024 Production and Operations Update

Retrieved on: 
Monday, April 1, 2024

TORONTO, Ontario and BROSSARD, Québec, April 01, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/ TSX: BITF), a global vertically integrated Bitcoin mining company, provides its monthly production report and update on its fleet upgrade and expansion.

Key Points: 
  • - Upgrade and expansion plan, targeting 21 EH/s and 21w/TH in 2024, underway with T21 deliveries and installations -
    TORONTO, Ontario and BROSSARD, Québec, April 01, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/ TSX: BITF), a global vertically integrated Bitcoin mining company, provides its monthly production report and update on its fleet upgrade and expansion.
  • Together, with our 35,888 Bitmain T21 purchases and farm expansions announced in November, these new 87,796 miners are sufficient to reach 21 EH/s by year-end, with greater operating efficiency.
  • “These orders solidify our expansion plan for 2024 and provide the pathway to operating one of the newest and potentially most efficient mining fleets in the industry.
  • Ben Gagnon, Chief Mining Officer, said, “In March, we received 1,650 T21 miners with 6,400 additional miners in transit.